Research Topics
| Anthony LucciSummaryAffiliation: The University of Texas Country: USA Publications
| Collaborators
|
Detail Information
Publications
Circulating tumour cells in non-metastatic breast cancer: a prospective studyAnthony Lucci
Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
Lancet Oncol 13:688-95. 2012..Our aim was to establish if circulating tumour cells predicted worse outcome in patients with non-metastatic breast cancer...- Cyclooxygenase-2 expression in primary breast cancers predicts dissemination of cancer cells to the bone marrowAnthony Lucci
Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, Houston, 77030, USA
Breast Cancer Res Treat 117:61-8. 2009.... 
Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011Anthony Lucci
Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
J Clin Oncol 25:3657-63. 2007..The current study compares complications associated with SLN dissection (SLND) plus ALND, versus SLND alone...- Assessment of the current Medicare reimbursement system for breast cancer operationsAnthony Lucci
Michael E DeBakey Department of Surgery and the Breast Care Center at Baylor College of Medicine, The Methodist Hospital, Houston, Texas, USA
Ann Surg Oncol 11:1037-44. 2004..Since no mechanism exists to consider outcomes in calculating reimbursements, we hypothesized that Medicare reimbursements do not correlate with outcomes for different breast cancer operations... - Evaluation of a CXCR4 antagonist in a xenograft mouse model of inflammatory breast cancerBalraj Singh
Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
Clin Exp Metastasis 27:233-40. 2010..05). However, CTCE-9908 as a single therapy inhibited organ-specific metastasis to leg (P < 0.05 by chi-squared test and by two-sample t-test)... 
Prospective assessment of postoperative complications and associated costs following inguinal lymph node dissection (ILND) in melanoma patientsSharon B Chang
Department of Surgical Oncology, University of Texas M D Anderson Cancer Center, Houston, TX, USA
Ann Surg Oncol 17:2764-72. 2010..We prospectively assessed the incidence, risk factors, and costs associated with wound complications and lymphedema in melanoma patients undergoing inguinal lymph node dissection (ILND)...- Role of primary tumor characteristics in predicting positive sentinel lymph nodes in patients with ductal carcinoma in situ or microinvasive breast cancerMin Yi
Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX, USA
Am J Surg 196:81-7. 2008..We determined the incidence of positive sentinel lymph nodes (SLNs) in patients with ductal carcinoma in situ (DCIS) or microinvasive breast cancer (MIC) and the predictive factors of SLN metastasis in these patients... - Biology, treatment, and outcome in very young and older women with DCISRosalinda Alvarado
Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Ann Surg Oncol 19:3777-84. 2012..This study examines a modern cohort of women with ductal carcinoma-in-situ (DCIS) in order to identify potential differences in clinical presentation, treatments, and outcome based on age... - American College of Surgeons Oncology Group (ACOSOG) Z0011: impact on surgeon practice patternsAbigail S Caudle
Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Ann Surg Oncol 19:3144-51. 2012..The ACOSOG Z0011 trial has been described as practice-changing. The goal of this study was to determine the impact of the trial on surgeon practice patterns at our institution... - HER2 status predicts the presence of circulating tumor cells in patients with operable breast cancerJulie E Lang
Department of Surgical Oncology, MD Anderson Cancer Center, Advanced Research Center for Microscopic Disease, The University of Texas, Houston, TX 77030, USA
Breast Cancer Res Treat 113:501-7. 2009..We hypothesized that primary tumor characteristics would predict the likelihood of identifying CTCs in patients with operable breast cancer... - Management of local-regional recurrence following immediate breast reconstruction in patients with early breast cancer treated without postmastectomy radiotherapyRanjna Sharma
Department of Surgical Oncology, Plastic Surgery, Radiation Oncology, and Breast Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
Plast Reconstr Surg 127:1763-72. 2011.... - Pretreatment staging positron emission tomography/computed tomography in patients with inflammatory breast cancer influences radiation treatment field designsGary V Walker
Department of Radiation Oncology, The Morgan Welch Inflammatory Breast Cancer Clinic, University of Texas MD Anderson Cancer Center, Houston, Texas, USA
Int J Radiat Oncol Biol Phys 83:1381-6. 2012..The purpose of this study was to define how pretreatment PET/CT studies affected postmastectomy radiation treatment (PMRT) planning decisions for IBC... - Evaluation of a breast cancer nomogram for predicting risk of ipsilateral breast tumor recurrences in patients with ductal carcinoma in situ after local excisionMin Yi
Department of Surgical Oncology, Unit 1484, The University of Texas MD Anderson Cancer Center, 1400 Pressler St, Houston, TX 77030, USA
J Clin Oncol 30:600-7. 2012..The aim of our study was to evaluate a published nomogram from Memorial Sloan-Kettering Cancer Center to predict for risk of IBTR in patients with DCIS from our institution... - Impact of preoperative versus postoperative chemotherapy on the extent and number of surgical procedures in patients treated in randomized clinical trials for breast cancerJudy C Boughey
Department of Surgical Oncology, MD Anderson Cancer Center, Houston, TX 77030, USA
Ann Surg 244:464-70. 2006..05). CONCLUSIONS: Among patients treated with BCT for larger breast tumors, patients treated with preoperative chemotherapy have less extensive resection, with no change in rates of re-excision... - Ductal carcinoma-in-situ of the breast with subsequent distant metastasis and deathRobert E Roses
Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX, USA
Ann Surg Oncol 18:2873-8. 2011..The rare patient diagnosed with pure ductal carcinoma-in-situ (DCIS) develops distant breast cancer metastases (DM). We sought to identify clinical and pathologic predictors of DM... - Cytologically proven axillary lymph node metastases are eradicated in patients receiving preoperative chemotherapy with concurrent trastuzumab for HER2-positive breast cancerLaura S Dominici
Department of Surgical Oncology, Brigham and Women s Hospital, Boston, MA, USA
Cancer 116:2884-9. 2010..To the authors' knowledge, the rate of eradication of biopsy-proven axillary lymph node metastases with trastuzumab-containing neoadjuvant chemotherapy regimens has not been previously reported... - Role of COX-2 in tumorospheres derived from a breast cancer cell lineBalraj Singh
Department of Surgical Oncology and Advanced Research Center for Microscopic Disease, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
J Surg Res 168:e39-49. 2011..quot;Stem-like" phenotype may be important in cancer metastasis... - Lymph node ratio predicts disease-specific survival in melanoma patientsYan Xing
Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030 4009, USA
Cancer 115:2505-13. 2009..The objectives of this analysis were to compare various measures associated with lymph node (LN) dissection and to identify threshold values associated with disease-specific survival (DSS) outcomes in patients with melanoma... - Disseminated tumor cells predict survival after neoadjuvant therapy in primary breast cancerCarolyn Hall
Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA
Cancer 118:342-8. 2012..Neoadjuvant chemotherapy (NACT) is effective in reducing the size of primary tumors or eradicating lymph node metastases before surgery, but little is known regarding the presence or significance of DTCs after NACT... - Inflammatory breast cancer: the disease, the biology, the treatmentFredika M Robertson
Department of Experimental Therapeutics, The University of Texas M D Anderson Cancer Center, Houston, TX, USA
CA Cancer J Clin 60:351-75. 2010..This review examines IBC's unique clinical presentation, pathology, epidemiology, imaging, and biology and details current multidisciplinary management of the disease, which comprises systemic therapy, surgery, and radiation therapy... - How many sentinel lymph nodes are enough during sentinel lymph node dissection for breast cancer?Min Yi
Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
Cancer 113:30-7. 2008..The objective of this study was to determine how many SLNs need to be removed for accurate lymph node staging and which patient and tumor characteristics influence this number... - Detection of minimal residual disease in blood and bone marrow in early stage breast cancerSavitri Krishnamurthy
Department of Pathology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
Cancer 116:3330-7. 2010..In this study, the authors investigated the occurrence of CTCs and DTCs in women with early stage breast cancer and evaluated the correlation of their presence with other prognostic markers... - Local, regional, and systemic recurrence rates in patients undergoing skin-sparing mastectomy compared with conventional mastectomyMin Yi
Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
Cancer 117:916-24. 2011..The purpose of this study was to examine the rates of local, regional, and systemic recurrence, and survival in breast cancer patients who underwent skin-sparing mastectomy (SSM) or conventional mastectomy (CM) at our institution... - Does blue dye contribute to success of sentinel node mapping for breast cancer?Taewoo Kang
Department of Surgical Oncology, M D Anderson Cancer Center, The University of Texas, Houston, TX, USA
Ann Surg Oncol 17:280-5. 2010..We sought to evaluate the utilization of blue dye in addition to radioisotope and its relative contribution to sentinel lymph node (SLN) mapping at a high-volume institution... - Neoadjuvant chemotherapy in invasive lobular carcinoma may not improve rates of breast conservationJudy C Boughey
Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, Houston, USA
Ann Surg Oncol 16:1606-11. 2009..This study was intended to evaluate the impact of neoadjuvant chemotherapy in ILC on breast-conserving surgery (BCS) rates... - Inflammatory breast cancer: what we know and what we need to learnHideko Yamauchi
Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
Oncologist 17:891-9. 2012..We review the current status of multidisciplinary care for patients with inflammatory breast cancer (IBC) and discuss what further research is needed to advance the care of patients with this disease... - Biologic features and prognosis of ductal carcinoma in situ are not adversely impacted by initial large body massHenry M Kuerer
Department of Surgical Oncology, DCIS Discovery Enterprise, Unit 1484, The University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Houston, TX 77230 1402, USA
Breast Cancer Res Treat 133:1131-41. 2012..Furthermore, there was no significant difference in risk of recurrence between diabetic patients receiving metformin or not. In conclusion, higher BMI is not associated with adverse biologic features or prognosis in patients with DCIS... - A CXCR4 antagonist CTCE-9908 inhibits primary tumor growth and metastasis of breast cancerEugene H Huang
Department of Radiation Oncology, The University of Texas, M D Anderson Cancer Center, Houston, Texas 77030, USA
J Surg Res 155:231-6. 2009..Our purpose was to determine whether inhibition of CXCR4 with a peptide-based antagonist would reduce tumor growth and metastasis of breast cancer... - Epidermal growth factor receptor tyrosine kinase inhibitor reverses mesenchymal to epithelial phenotype and inhibits metastasis in inflammatory breast cancerDongwei Zhang
Breast Cancer Translational Research Laboratory, Department of Breast Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
Clin Cancer Res 15:6639-48. 2009..Epidermal growth factor receptor (EGFR) expression is an independent poor prognostic factor in IBC. The purpose of this study was to determine the effect on IBC tumorigenicity and metastasis of blocking the EGFR pathway... - Cyclooxygenase-2 induces genomic instability, BCL2 expression, doxorubicin resistance, and altered cancer-initiating cell phenotype in MCF7 breast cancer cellsBalraj Singh
Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas, USA
J Surg Res 147:240-6. 2008..We also analyzed cell cultures grown as mammospheres to determine whether COX2 expression affects the cancer-initiating ("stem") cell phenotype in MCF7 cells... - Present-day locoregional control in patients with t1 or t2 breast cancer with 0 and 1 to 3 positive lymph nodes after mastectomy without radiotherapyRanjna Sharma
Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX, USA
Ann Surg Oncol 17:2899-908. 2010..We sought to determine present-day locoregional recurrence (LRR) rates to better understand the role of postmastectomy radiotherapy (PMRT) in women with 0 to 3 positive lymph nodes... - Disseminated tumor cells in biologic subtypes of stage I-III breast cancer patientsCarolyn Hall
Department of Surgical Oncology, Unit 444, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Ann Surg Oncol 17:3252-8. 2010..Conversely, late recurrences are seen in estrogen receptor (ER)-positive (luminal) cancers. Disseminated tumor cells (DTCs) may be responsible for late recurrences. We compared rates of DTCs in basal and luminal subtypes... - Classification of ipsilateral breast tumor recurrences after breast conservation therapy can predict patient prognosis and facilitate treatment planningMin Yi
Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, TX, USA
Ann Surg 253:572-9. 2011..We utilized 2 different methods and compared sensitivities and specificities between them. Our goal was to determine whether distinguishing NP from TR had prognostic value... - Conditional survival estimates improve over time for patients with advanced melanoma: results from a population-based analysisYan Xing
Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030 4009, USA
Cancer 116:2234-41. 2010..The objective of this analysis was to provide melanoma-specific CS estimates to help clinicians promote more informed patient decision making... - Sentinel lymph node dissection provides axillary control equal to complete axillary node dissection in breast cancer patients with lobular histology and a negative sentinel nodeNazanin Khakpour
Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA
Am J Surg 190:598-601. 2005..CONCLUSIONS: SLND provided axillary control equivalent to that of ALND for patients with lobular breast cancer. SLND alone appears to be adequate axillary management of patients with lobular breast cancer and a negative sentinel node... - Polycomb group protein EZH2 is frequently expressed in inflammatory breast cancer and is predictive of worse clinical outcomeYun Gong
Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA
Cancer 117:5476-84. 2011..In this retrospective study, the authors examined EZH2 expression in IBC tumors and evaluated the relation between EZH2 expression and patient survival... - A prospective study comparing touch imprint cytology, frozen section analysis, and rapid cytokeratin immunostain for intraoperative evaluation of axillary sentinel lymph nodes in breast cancerSavitri Krishnamurthy
Department of Pathology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
Cancer 115:1555-62. 2009.... - Validation of a breast cancer nomogram for predicting nonsentinel lymph node metastases after a positive sentinel node biopsyLaura A Lambert
Department of Surgical Oncology, Unit 444, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030, USA
Ann Surg Oncol 13:310-20. 2006..TIC seems to be an acceptable substitute for frozen section as a nomogram variable. The nomogram may help predict an individual's risk of non-SLN metastases and assist in patient decision making regarding the benefit of CLND... - COX-2 induces IL-11 production in human breast cancer cellsBalraj Singh
Department of Surgical Oncology, University of Texas, M.D. Anderson Cancer Center, Houston, Texas 77030, USA
J Surg Res 131:267-75. 2006..CONCLUSION: COX-2-mediated production of IL-11 in breast cancer cells may be vital to the development of osteolytic bone metastases in patients with breast cancer, and a COX-2 inhibitor may be useful in inhibiting this process... - Primary breast cancer patients with high risk clinicopathologic features have high percentages of bone marrow epithelial cells with ALDH activity and CD44⁺CD24lo cancer stem cell phenotypeJames M Reuben
Department of Hematopathology, Unit 54, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA
Eur J Cancer 47:1527-36. 2011..Therefore, we assessed the presence of Aldefluor(+) epithelial (CD326(+)CD45(dim)) cells for the presence of the CD44(+)CD24(lo) phenotype in BM of patients with primary breast cancer (PBC)... - The safety of breast-conserving surgery in patients who achieve a complete pathologic response after neoadjuvant chemotherapyFlorentia Peintinger
Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA
Cancer 107:1248-54. 2006..Prospective studies are needed to examine whether decreasing the RVs in this patient population leads to an increased LRR rate... - Selection of metastatic breast cancer cells based on adaptability of their metabolic stateBalraj Singh
Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
PLoS ONE 7:e36510. 2012..As we decreased the number of cancer cells in xenografts, lung metastasis and then primary tumor growth was impaired in mice injected with parental cell line, but not in mice injected with Gln-ind cells... - Expression of epithelial-mesenchymal transition-inducing transcription factors in primary breast cancer: The effect of neoadjuvant therapyMichal Mego
Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Int J Cancer 130:808-16. 2012..In summary, our results demonstrate that CTCs with EMT phenotype may occur in the peripheral circulation of patients with PBC and that NAT is unable to eliminate CTCs undergoing EMT... - Fibrin sealant does not decrease seroma output or time to drain removal following inguino-femoral lymph node dissection in melanoma patients: a randomized controlled trial (NCT00506311)Melinda M Mortenson
Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas, USA
World J Surg Oncol 6:63. 2008.... - Biologic and immunologic effects of preoperative trastuzumab for ductal carcinoma in situ of the breastHenry M Kuerer
Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas, USA
Cancer 117:39-47. 2011..Through this study, the authors sought to investigate the biologic and immunologic effects of preoperative trastuzumab in patients with ductal carcinoma in situ (DCIS) of the breast... - Breast cancer in the very elderly: treatment patterns and complications in a tertiary cancer centerKari M Rosenkranz
MD Anderson Cancer Center, Department of Surgical Oncology, 1515 Holcombe Blvd, Houston, TX 77030, USA
Am J Surg 192:541-4. 2006..We performed a retrospective review of the very elderly population treated at our institution in order to assess treatment patterns and the safety of therapy in an older population... - Impact of clinical and pathologic features on tumor-infiltrating lymphocyte expansion from surgically excised melanoma metastases for adoptive T-cell therapyRichard W Joseph
Department of Melanoma Medical Oncology, The University of Texas, M D Anderson Cancer Center, Houston, Texas 77030, USA
Clin Cancer Res 17:4882-91. 2011..However, little is known how clinical and pathologic features impact TIL outgrowth isolated from metastatic melanoma tumors... - Differential regulation of the aggressive phenotype of inflammatory breast cancer cells by prostanoid receptors EP3 and EP4Fredika M Robertson
Department of Experimental Therapeutics, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
Cancer 116:2806-14. 2010.... - Overexpression of COX-2 in celecoxib-resistant breast cancer cell linesBalraj Singh
Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
J Surg Res 163:235-43. 2010..Herein we tested the hypothesis that celecoxib-resistance involves selection of cancer cells that overexpress COX-2... - Reduced incidence of breast cancer-related lymphedema following mastectomy and breast reconstruction versus mastectomy aloneAnnika Card
Department of Plastic Surgery and the Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77230 1402, USA
Plast Reconstr Surg 130:1169-78. 2012..To determine whether breast cancer reconstruction has an impact on the incidence of breast cancer-related lymphedema, the authors compared its incidence in patients who underwent mastectomy with reconstruction versus mastectomy alone... - Variability in melanoma post-treatment surveillance practices by country and physician specialty: a systematic reviewKate D Cromwell
Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030 4009, USA
Melanoma Res 22:376-85. 2012..As the number of melanoma survivors increases, it will be critical to examine the benefits and costs of various follow-up strategies to establish consensus guidelines for melanoma post-treatment surveillance... - Significance of micrometastasis in bone marrow and blood of operable breast cancer patients: research tool or clinical application?Julie E Lang
The University of Texas MD Anderson Cancer Center, Department of Surgical Oncology, Unit 444, 1515 Holcombe Blvd, Houston, TX 77030, USA
Expert Rev Anticancer Ther 7:1463-72. 2007..The purpose of this report is to review the data regarding CTCs and DTCs in patients with operable breast cancer... - Invasive lobular carcinoma predicts micrometastasis in breast cancerSarah M Gainer
Department of Surgical Oncology, The University of Texas, MD, Anderson Cancer Center, Houston, Texas 77030, USA
J Surg Res 177:93-6. 2012..Disseminated tumor cells (DTCs) and circulating tumor cells (CTCs) have been implicated in recurrence. The purpose of this study was to determine whether DTCs and CTCs are associated with ILCs in stage I-III breast cancer... - Trastuzumab in Primary Inflammatory Breast Cancer (IBC): High Pathological Response Rates and Improved OutcomeShaheenah Dawood
Departments of Breast Medical Oncology, Pathology, Quantitative Sciences, Radiotherapy and Surgical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas and Department of Medical Oncology, Dubai Hospital, Dubai, UAE
Breast J . 2010..CXCR4 may represent a novel therapeutic target... - Triple-negative subtype predicts poor overall survival and high locoregional relapse in inflammatory breast cancerJing Li
Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA
Oncologist 16:1675-83. 2011..However, these findings have not been confirmed for inflammatory breast cancer (IBC), which has different biological features than non-IBC... - Characterizing cancer cells with cancer stem cell-like features in 293T human embryonic kidney cellsBisrat G Debeb
Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Mol Cancer 9:180. 2010..Herein we fully characterize cancer stem cell-like features in 293T human embryonic kidney cells... - Novel clinical trial designs for treatment of ductal carcinoma in situ of the breast with trastuzumab (herceptin)Ricardo J Gonzalez
Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA
Breast J 13:72-5. 2007.... - Cyclooxygenase-2 expression induces genomic instability in MCF10A breast epithelial cellsBalraj Singh
Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
J Surg Res 140:220-6. 2007..We hypothesized that the induction of genomic instability is a major mechanism through which COX-2 contributes to breast cancer progression... - Involvement of IL-8 in COX-2-mediated bone metastases from breast cancerBalraj Singh
Department of Surgical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA
J Surg Res 134:44-51. 2006..CONCLUSION: COX-2 expression induced formation of PGE2 and IL-8 in breast cancer cells. Since PGE2 and IL-8 stimulate osteoclasts to resorb bone, COX-2 inhibition is a potential target for treatment to prevent bone metastases... - Intramammary lymph node presenting as the primary breast mass in infiltrating lobular carcinomaAndreana L Rivera
Department of Pathology, Baylor College of Medicine, Houston, Texas, USA
Curr Surg 63:107-9. 2006 - Changing behavior in clinical practice in response to the ACOSOG Z0011 trial: a survey of the American Society of Breast SurgeonsSarah M Gainer
Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
Ann Surg Oncol 19:3152-8. 2012..The current study was undertaken to evaluate the impact of Z0011 on surgical practice nationally... - Lymphoscintigraphy does not enhance sentinel node identification or alter management of patients with early breast cancerAngela Shoher
Department of Surgery, Baylor College of Medicine, and The University of Texas MD Anderson Cancer Center, Houston, Texas 77230-1402, USA
Curr Surg 63:207-12. 2006..Drainage to extraaxillary sites was rare. LS findings did not enhance success of intraoperative identification of SN or alter the postoperative management of patients with early stage breast cancer... - COX-2 overexpression increases motility and invasion of breast cancer cellsBalraj Singh
Michael E DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX 77030, USA
Int J Oncol 26:1393-9. 2005..In this study, we conclude that COX-2 overexpression in human breast cancer cells enhances cell motility and invasiveness thus suggesting a mechanism of COX-2 mediated metastasis... - Prospective randomized trial of paravertebral block for patients undergoing breast cancer surgeryJudy C Boughey
Department of Surgery, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA
Am J Surg 198:720-5. 2009..The goal of the current study was to evaluate the effect of regional anesthesia using paravertebral block (PVB) on postoperative pain after breast surgery... - Different gene expressions are associated with the different molecular subtypes of inflammatory breast cancerTakayuki Iwamoto
Breast Cancer Translational Research Laboratory, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
Breast Cancer Res Treat 125:785-95. 2011..IBC tumors can be divided into molecular and clinical subtypes similar to those of non-IBC. Clinical subtypes of IBC show molecular differences compared with similar subtypes of non-IBC... - Emerging patterns of practice in the implementation and application of sentinel lymph node biopsy in breast cancer patients in the United StatesAngela Shoher
Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas 77030, USA
J Surg Oncol 83:65-7. 2003 - Mastectomy performed with scissors following tumescent solution injectionAngela Shoher
Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas 77030, USA
J Surg Oncol 83:191-3. 2003 - Differential radiosensitizing effect of valproic acid in differentiation versus self-renewal promoting culture conditionsBisrat G Debeb
Division of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 76:889-95. 2010..From these data, we hypothesized that VA would fail to radiosensitize breast cancer stem/progenitor cells grown to three-dimensional (3D) mammospheres... - Atypical dermatofibrosarcoma protuberans in the breastVijay Ramakrishnan
Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX 77030, USA
Breast J 11:217-8. 2005 - Neoadjuvant trastuzumab and docetaxel in breast cancer: preliminary resultsAndrea E Van Pelt
Department of Surgery, Methodist Hospital, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA
Clin Breast Cancer 4:348-53. 2003..A high rate of brain metastasis was noted, particularly in patients with baseline metastatic disease... - Melanoma adrenal metastasis: natural history and surgical managementElizabeth A Mittendorf
Department of Surgical Oncology, Unit 444, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
Am J Surg 195:363-8; discussion 368-9. 2008..Few data exist regarding melanoma metastasis to the adrenal gland. We reviewed our experience to determine the natural history of this condition and the appropriate role for surgical intervention... - Synergistic tumoricidal effect between celecoxib and adenoviral-mediated delivery of mda-7 in human breast cancer cellsYoung-Jin Suh
Department of Surgical Oncology, The University of Texas, M. D. Anderson Cancer Center, Houston, TX 77030-4009, USA
Surgery 138:422-30. 2005..This occurs through inhibition of COX-2 expression and down-regulation of Akt. Combining Ad-mda7 with COX-2 inhibition provides a novel method of treatment in breast cancer... - Oncoplastics: techniques for reconstruction of partial breast defects based on tumor locationSarah M Gainer
Department of Surgical Oncology, The Methodist Hospital, Houston, Texas 77030, USA
J Surg Oncol 103:341-7. 2011..The field of oncoplastics has also become increasingly popular and seeks to prevent these contour deformities during BCT. This review approaches oncoplastic reconstruction by outlining different techniques based on tumor location... - Surgical treatment of pregnancy associated breast cancerKari M Rosenkranz
The University of Texas M.D. Anderson Cancer Center, Houston, 77230-1402, USA
Breast Dis 23:87-93. 2005..Neoadjuvant chemotherapy, sentinel node biopsy and breast conservation are now considered safe modalities in properly chosen pregnant patients... - Role of cyclooxygenase-2 in breast cancerBalraj Singh
Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas 77030, USA
J Surg Res 108:173-9. 2002..It is likely that the COX-2 inhibitors will be effective in the treatment regimens involving combination chemotherapies... - Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trialLee Gravatt Wilke
Department of Surgery, Duke University Medical Center, Durham, North Carolina, USA
Ann Surg Oncol 13:491-500. 2006..CONCLUSIONS: This study provides a prospective assessment of the sentinel lymph node biopsy procedure, as performed by a wide range of surgeons, demonstrating a low complication rate... - Is axillary dissection needed when the sentinel node is positive? No: it is time to rethink axillary lymph node dissection when the sentinel node is positiveAnthony Lucci
J Surg Oncol 97:201-2. 2008 - Re: Clinical implications of sentinel nodes outside the axilla and internal mammary chain in patients with breast cancer, by van Rijk MC, Tanis PJ, Nieweg OE, et alAnthony Lucci
J Surg Oncol 94:266-8. 2006 - A gene signature in breast cancerWendy A Woodward
N Engl J Med 356:1887-8; author reply 1887-8. 2007 - Orthopedic surgery implications of breast cancerGerman A Marulanda
Department of Orthopedics and Sports Medicine, University of South Florida, 3500 E Fletcher Avenue, Suite 511, MDC106 Tampa, FL 33613, USA
Expert Rev Anticancer Ther 8:949-56. 2008..Orthopedic surgeons should establish an active role in the multidisciplinary treatment of patients with breast cancer...